Literature DB >> 23568423

European content validation of the Self-Assessment Goal Achievement (SAGA) questionnaire in patients with overactive bladder.

Vik Khullar1, Daniela Marschall-Kehrel, Montserrat Espuna-Pons, Con J Kelleher, Shannon E Tully, Elisabeth C Piault, Linda Brubaker, Aino Fianu-Jonasson, David Weinstein, Agneta Bergqvist, Marion Kvasz.   

Abstract

INTRODUCTION AND HYPOTHESIS: The Self-Assessment Goal Achievement (SAGA) questionnaire is a patient-completed instrument designed to assess goal attainment in the behavioral or pharmacologic treatment of lower urinary tract symptoms (LUTS), including overactive bladder (OAB). The SAGA questionnaire allows patients to identify and rank the importance of treatment goals before treatment is initiated; the follow-up SAGA questionnaire quantifies the achievement of these patient-identified goals. The objective of this qualitative research was to confirm the content validity of the German, Spanish, Swedish, and English (UK) language versions of the SAGA questionnaire in patients with OAB with or without other LUTS.
METHODS: The SAGA questionnaire was translated to each language in accordance with a well-established forward and backward harmonization method. Patient interviews were then conducted according to a cognitive debriefing methodology. Qualitative analysis of patients' input allowed assessment of content validity of each linguistically adapted SAGA questionnaire.
RESULTS: All patients (n = 29; six to eight per targeted country) found the SAGA questionnaire easy to understand and to complete. Most patients completed the nine prespecified (fixed) treatment goals and were able to add up to five personal goals in the open-ended portion and rate each goal by importance. Differences were identified in how the various languages communicated some of the concepts assessed with the SAGA questionnaire. Rewording of the translated versions of the questionnaire was necessary in some cases.
CONCLUSIONS: This linguistic content validation study in four European languages indicates that SAGA is a comprehensive, easy-to-understand, and relevant questionnaire for patient-completed evaluation of LUTS/OAB symptoms and treatment goal attainment.

Entities:  

Mesh:

Year:  2013        PMID: 23568423     DOI: 10.1007/s00192-012-2039-x

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN: 0937-3462            Impact factor:   2.894


  26 in total

Review 1.  The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society.

Authors:  Paul Abrams; Linda Cardozo; Magnus Fall; Derek Griffiths; Peter Rosier; Ulf Ulmsten; Philip Van Kerrebroeck; Arne Victor; Alan Wein
Journal:  Urology       Date:  2003-01       Impact factor: 2.649

Review 2.  Persistence and adherence in the treatment of overactive bladder syndrome with anticholinergic therapy: a systematic review of the literature.

Authors:  C C Sexton; S M Notte; C Maroulis; R R Dmochowski; L Cardozo; D Subramanian; K S Coyne
Journal:  Int J Clin Pract       Date:  2011-05       Impact factor: 2.503

3.  A randomized crossover trial to examine administration techniques related to the Bristol female lower urinary tract symptom (BFLUTS) questionnaire.

Authors:  Mohid S Khan; Charlotte Chaliha; Lucia Leskova; Vik Khullar
Journal:  Neurourol Urodyn       Date:  2005       Impact factor: 2.696

4.  Principles of Good Practice for the Translation and Cultural Adaptation Process for Patient-Reported Outcomes (PRO) Measures: report of the ISPOR Task Force for Translation and Cultural Adaptation.

Authors:  Diane Wild; Alyson Grove; Mona Martin; Sonya Eremenco; Sandra McElroy; Aneesa Verjee-Lorenz; Pennifer Erikson
Journal:  Value Health       Date:  2005 Mar-Apr       Impact factor: 5.725

5.  Defining efficacy in the treatment of overactive bladder syndrome.

Authors:  Sagar Shah; Victor W Nitti
Journal:  Rev Urol       Date:  2009

6.  Goal attainment scaling in patients with lower urinary tract symptoms: development and pilot testing of the Self-Assessment Goal Achievement (SAGA) questionnaire.

Authors:  Linda Brubaker; Vik Khullar; Elisabeth Piault; Christopher J Evans; Tamara Bavendam; James Beach; Yating Yeh; Zoe S Kopp; Con J Kelleher; Jeffrey Trocio
Journal:  Int Urogynecol J       Date:  2011-03-04       Impact factor: 2.894

7.  Overactive bladder in women: symptom impact and treatment expectations.

Authors:  Scott MacDiarmid; Matt Rosenberg
Journal:  Curr Med Res Opin       Date:  2005-09       Impact factor: 2.580

Review 8.  An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction.

Authors:  Bernard T Haylen; Dirk de Ridder; Robert M Freeman; Steven E Swift; Bary Berghmans; Joseph Lee; Ash Monga; Eckhard Petri; Diaa E Rizk; Peter K Sand; Gabriel N Schaer
Journal:  Neurourol Urodyn       Date:  2010       Impact factor: 2.696

9.  Patient-reported reasons for discontinuing overactive bladder medication.

Authors:  Joshua S Benner; Michael B Nichol; Eric S Rovner; Zhanna Jumadilova; Jose Alvir; Mohamed Hussein; Kristina Fanning; Jeffrey N Trocio; Linda Brubaker
Journal:  BJU Int       Date:  2009-11-12       Impact factor: 5.588

10.  Linguistic validation of translation of the Self-Assessment Goal Achievement (SAGA) questionnaire from English.

Authors:  Elisabeth Piault; Sameepa Doshi; Barbara A Brandt; Çolpan Angün; Christopher J Evans; Agneta Bergqvist; Jeffrey Trocio
Journal:  Health Qual Life Outcomes       Date:  2012-04-23       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.